Concourse Financial Group Securities, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 55 shares of REGN stock, worth $39,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 46 19.57%

Holding current value

$39,417

Previous $48,000 18.75%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$1024.09 - $1201.76 $9,216 - $10,815	9 Added 19.57%	55 $57,000
Q2 2024 Jul 23, 2024	BUY	$883.2 - $1071.19 $5,299 - $6,427	6 Added 15.0%	46 $48,000
Q1 2024 Apr 30, 2024	BUY	$902.69 - $993.35 $10,832 - $11,920	12 Added 42.86%	40 $38,000
Q4 2023 Feb 07, 2024	BUY	$775.18 - $881.7 $5,426 - $6,171	7 Added 33.33%	28 $24,000
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $692 - $844	-1 Reduced 4.55%	21 $17,000
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $3,500 - $4,151	5 Added 29.41%	22 $15,000
Q4 2022 Jan 30, 2023	BUY	$705.89 - $766.39 $3,529 - $3,831	5 Added 41.67%	17 $0
Q3 2022 Nov 15, 2022	BUY	$573.97 - $724.32 $6,313 - $7,967	11 Added 1100.0%	12 $8,000
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $2,741 - $3,694	-5 Reduced 83.33%	1 $1,000
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $166,038 - $194,861	-279 Reduced 97.89%	6 $4,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $1,630 - $2,012	3 Added 1.06%	285 $180,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $20,665 - $24,514	36 Added 14.63%	282 $171,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $2,836 - $3,351	-6 Reduced 2.38%	246 $137,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $75,050 - $92,097	168 Added 200.0%	252 $119,000
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $59,309 - $75,389	-124 Reduced 59.62%	84 $41,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $80,078 - $96,756	147 Added 240.98%	208 $116,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2,959 - $3,863	6 Added 10.91%	61 $38,000
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $3,361 - $4,944	-10 Reduced 15.38%	55 $27,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $17,818 - $24,473	65 New	65 $24,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $20,509 - $23,879	-75 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $28,162 - $38,993	-94 Reduced 55.62%	75 $23,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $35,719 - $42,198	96 Added 131.51%	169 $69,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $24,514 - $29,421	73 New	73 $27,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $0 - $0	0 New	0 $0

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Regeneron Pharmaceuticals, Inc. Transaction History